Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study

Table 1 The baseline characteristics of the enrolled treatment-naïve chronic hepatitis B patients with normal or minimally raised alanine aminotransferase levels

Characteristics (n = 63)
Sex, male/female	37/26
Age, mean (± SD) yr	50.8 (± 8.9)
Body mass index, mean (± SD) kg/m2	23.4 (± 3.4)
AST, mean (± SD), IU/L (normal 4-40 IU/L)	43.5 (± 22.6)
ALT, mean (± SD), IU/L (normal 4-40 IU/L)	44.0 (± 20.8)
Platelet counts, mean (± SD), × 103/mm3	163.5 (± 39.4)
Prothrombin time, mean (± SD), INR	1.05 (± 0.08)
Total bilirubin, mean (± SD), mg/dL	0.75 (± 0.47)
Albumin, mean (± SD), g/dL	3.97 (± 0.24)
γ-glutamyl transferase, mean (± SD), U/L	47.5 (± 31.0)
HBeAg status, positive/negative	35/28
HBV-DNA, mean (± SD), log10 IU/mL	5.78 (± 1.64)
Grade of inflammatory activity (0/1/ 2/3)	9/26/15/13
Fibrosis stage (0/1/2/3 /4)	3/16/14/ 14/16

ALT: Alanine transaminase; AST: Aspartate transaminase; INR: International normalized ratio; SD: Standard deviation.